Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Go back to Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program| (AMEX: ONNVF) | Delayed: 0.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.46 | 52 Week High | $ | |||
| Open | $0.46 | 52 Week Low | $ | |||
| Day High | $0.46 | P/E | N/A | |||
| Day Low | $0.46 | EPS | $ | |||
| Volume | 84,522 | |||||
